Minor Cannabinoid Synthesis

Minor cannabinoid synthesis refers to the genetic pathways and enzymatic processes that produce cannabinoids present in lower concentrations than THC and CBD, including CBN, CBC, CBG, CBDV, and others. These compounds arise from variations in cannabinoid synthase enzymes and their substrate availability within the plant's resin glands. Breeding programs targeting minor cannabinoid profiles leverage both selective crosses and phenotype hunting to stabilize lines expressing elevated levels of specific minor cannabinoids. Lineage records frequently report that certain landrace and heritage genetics carry natural predispositions toward minor cannabinoid accumulation. Understanding synthesis pathways helps breeders work toward consistent, reproducible profiles beyond the THC/CBD binary. Genetic markers and biochemical testing now enable more precise selection for these traits.

Breeders working in minor cannabinoid categories use marker-assisted selection and progeny testing to identify and stabilize plants with variant synthase activity. Commercial breeding programs increasingly focus on CBG-dominant, CBN-forward, or CBDV-rich phenotypes to serve emerging market segments and research demands.